Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

GlycoMimetics Incorporated

ClinicalTrials.gov Identifier:

NCT01119833

First received: May 5, 2010

Last updated: March 11, 2013

Last verified: March 2013

History of Changes

Full Text View
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2013
Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

No publications provided by GlycoMimetics Incorporated

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

[No authors listed] Deal watch: Pfizer deal for selectin inhibitor highlights potential of glycomimetic drugs. Nat Rev Drug Discov. 2011 Dec 1;10(12):890. No abstract available.

To Top